SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (2254)6/3/1999 11:15:00 AM
From: Phil Cressman  Read Replies (2) | Respond to of 2742
 
Pasteur, Connaught etc., may be set to have news release related to cancer vacines in conjunction with NRC (National Research Council)on June 10th. Wonder if this will have any bearing on CIST? Picked this up from another thread relating to BIOM.



To: Walter Morton who wrote (2254)6/3/1999 1:04:00 PM
From: Steve Harmon  Respond to of 2742
 
KERA would have paid Cistron shareholders 65-70 cent a share for just our cash in Dec. 98. It is now June 99 and our shares are valued at just 26 cent a share.

The above could have been done by Richard H.'s "phone call" instructions.

No further dilution and no ONE year PAID vacations would have needed to be paid by us shareholders.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News